Avalo Therapeutics (AVTX) CLO logs tax-withholding of 1,081 shares on Form 4
Rhea-AI Filing Summary
Avalo Therapeutics Chief Legal Officer Paul Varki reported a tax-related share disposition. On this Form 4, 1,081 shares of common stock were withheld at $13.10 per share to satisfy tax obligations, a non-market transaction classified as a tax-withholding disposition.
Following this event, Varki directly holds 32,576 shares of Avalo Therapeutics common stock. A footnote explains that this total includes 5,723 shares acquired through the company’s Employee Stock Purchase Plan as part of this reporting transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,081 shares
Net Sell
1 txn
Insider
VARKI PAUL
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,081 | $13.10 | $14K |
Holdings After Transaction:
Common Stock — 32,576 shares (Direct)
Footnotes (1)
- F1. Includes 5,723 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan as a part of this reporting transaction.
Key Figures
Tax-withholding shares: 1,081 shares
Tax-withholding price: $13.10 per share
Shares held after transaction: 32,576 shares
+1 more
4 metrics
Tax-withholding shares
1,081 shares
Common Stock withheld to cover tax liability
Tax-withholding price
$13.10 per share
Price used for tax-withholding disposition
Shares held after transaction
32,576 shares
Direct common stock ownership after disposition
ESPP shares included
5,723 shares
Acquired via Employee Stock Purchase Plan as part of this transaction
Key Terms
tax-withholding disposition, Employee Stock Purchase Plan, Common Stock
3 terms
tax-withholding disposition financial
"a non-market transaction classified as a tax-withholding disposition"
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
Employee Stock Purchase Plan financial
"includes 5,723 shares acquired through the company’s Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
Common Stock financial
"1,081 shares of common stock were withheld at $13.10 per share"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Avalo Therapeutics (AVTX) report for Paul Varki?
Avalo Therapeutics reported a tax-withholding disposition for Chief Legal Officer Paul Varki. The company withheld 1,081 common shares at $13.10 per share to cover tax liabilities, rather than an open-market sale, as shown in the Form 4 filing.
What role did Avalo Therapeutics’ Employee Stock Purchase Plan play in this Form 4?
A footnote states that 5,723 of Paul Varki’s reported shares were acquired through Avalo Therapeutics’ Employee Stock Purchase Plan. These ESPP shares are included in his 32,576 total direct holdings disclosed as of this Form 4 reporting transaction.
Does the Avalo Therapeutics (AVTX) Form 4 indicate open-market buying or selling by Paul Varki?
The Form 4 does not show open-market buying or selling by Paul Varki. Instead, it records a tax-withholding disposition, where 1,081 shares were delivered to cover tax liabilities, which is a routine administrative transaction rather than a discretionary market trade.